封面
市場調查報告書
商品編碼
2136469

2016-2026年醫院護理領域的合作與授權協議

Hospital Care Collaboration and Licensing Deals 2016-2026

出版日期: | 出版商: Current Partnering | 英文 400+ Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

讓我們透過 842 個案例研究中有關合作與許可協議的信息,來了解醫院護理領域合作的趨勢。

「2016-2026 年醫院護理合作與許可協議」提供了有關 842 項與醫院護理資產、技術和發展計劃相關的合作交易的全面資訊。

醫院醫療保健合作涵蓋廣泛領域,包括急診、住院治療以及醫院提供的各項干預措施。交易結構通常受臨床服務需求、專業知識、醫療保健系統整合以及將產品引入醫院環境的營運要求等因素的影響。

本報告將這些趨勢匯總到一個資源中,使用戶能夠了解哪些公司正在合作,哪些醫院護理機會吸引了人們的興趣,交易是如何構建的,披露了哪些財務條款,以及交易在不同治療適應症、技術和開發階段有何不同。

這份報告不僅僅是提供交易清單;它結合了全面的市場交易分析和財務基準、關鍵交易商的情報、詳細的交易記錄以及公開的合約文件。

本報告為醫院護理領域的業務發展、許可、研究和評估、公司策略、研發策略、競爭情報分析以及參與合作的法律團隊提供可操作的資訊和基準資源。

了解醫院護理領域目前的合作狀況

本報告分析了2016年至2026年醫院護理行業的交易情況,內容包括:

  • 醫院護理夥伴關係年度趨勢
  • 按交易類型分類的交易趨勢
  • 按行業
  • 合作關係發展階段
  • 技術類型
  • 治療指徵
  • 醫院醫療保健領域最活躍的交易商
  • 根據已披露的交易金額,主要交易
  • 醫院醫療領域合作活動的趨勢
  • 這使用戶能夠確定他們的活動集中在哪些方面,並了解哪些公司、技術、開發階段和治療領域正在吸引合作興趣。
  • 醫院醫療保健產業交易財務資訊的基準分析
  • 財務條款可能因資產、開發階段、技術、授予的權利以及交易的整體結構而有很大差異。

本報告對已揭露的財務狀況進行了詳細分析,包括以下內容:

  • 交易總額
  • 預付款
  • 里程碑付款
  • 版稅率
  • 透過分析這些基準背後的具體交易,用戶可以更全面地了解所揭露的經濟數據背後的經濟狀況。
  • 這為內部基準測試、機會評估、交易準備和談判提供了現實的參考點。
  • 財務基準只有在結合類似交易的結構和情況進行分析時才最有用,而不是作為單獨的平均值。本報告提供了建立這種背景所需的基本交易資訊。
  • 確定醫院護理領域的關鍵交易商和潛在合作夥伴。
  • 本報告列出了在醫院護理領域合作活動最活躍的公司,並提供交易歷史記錄,以便用戶可以調查其過去的活動。

這有助於用戶識別以下內容:

  • 積極尋求在醫院護理領域發展機會的公司
  • 有潛力的授權和合作夥伴
  • 曾多次在相關治療領域與之合作的組織
  • 積極參與開發過程的公司
  • 對特定技術或交付方式有興趣的交易撮合者
  • 競爭對手正在推廣相關的外部創新策略
  • 對於尋求醫院相關資產和技術合作夥伴的公司而言,過去的交易歷史可以提供寶貴的見解,了解哪些組織對類似的機會表現出了興趣。
  • 比較醫院醫學適應症和目標領域的合作活動。
  • 醫院醫療保健涵蓋各種治療需求和臨床環境,對開發、商業化和實施提出了不同的要求。
  • 本報告按治療適應症和治療標靶分析合作關係,使用戶能夠根據具體的項目和策略利益,以及廣泛的市場層級基準,確定最相關的交易。
  • 透過結合基於技術和發展階段的分析,用戶可以發現更多有意義的類似交易和潛在的未來合作夥伴關係。
  • 了解醫院醫療保健產業的合約結構
  • 本報告涵蓋合作、授權、開發、研發及其他合作交易。

根據交易詳情和資訊披露,用戶可以調查以下方面:

  • 授予和保留的權利
  • 負責研發工作
  • 授權權
  • 獨家版權
  • 區域權利
  • 智慧財產
  • 發展和監管義務
  • 負責生產和供應
  • 商業化權利
  • 金錢補償
  • 里程碑和版稅
  • 管治
  • 合約期限和終止條款
  • 這些例子為考慮醫院護理夥伴關係的適當框架提供了寶貴的見解。
  • 從實際合約文件中學習
  • 本報告提供了所選醫院護理交易的相關合約文件(如有)。

這些合約提供的資訊遠比簡單的公告詳細得多,使用戶能夠了解公司如何記錄以下內容:

  • 權利範圍
  • 發展義務
  • 智慧財產
  • 獨家版權
  • 財務狀況
  • 里程碑觸發條件
  • 特許權使用費規定
  • 商業化權利
  • 合約終止及其他談判事項
  • 對於準備和談判與醫院護理相關的合作和許可協議的團隊來說,獲取實際的合約措辭可以提供寶貴的見解,了解類似交易在實踐中的結構。
  • 綜合醫院護理交易目錄
  • 本報告包含 842 項醫院護理合作關係和許可協議的綜合目錄,為識別相關領先提供了詳細資訊來源。

可以使用以下條件搜尋交易記錄:

  • 公司
  • 技術類型
  • 治療適應症或標靶
  • 合約揭露狀態
  • 每筆交易都與其底層交易記錄相關聯,從而可以存取更多交易資訊和相關合約文件(如有)。
  • 這份報告適合哪些讀者?
  • 業務拓展與授權團隊
  • 識別類似的醫院醫療保健交易、潛在的未來合作夥伴關係以及相關的交易結構。
  • 探勘與評估團隊
  • 這樣一來,您就可以確定哪些公司正在積極探索醫院醫療保健領域在相關適應症、技術和發展階段的商業機會。
  • 尋求合作夥伴的生技公司
  • 找出對類似醫院醫療保健資產和技術表現出明確興趣的組織。
  • 企業策略與研發策略團隊
  • 我們將了解我們的競爭對手和潛在合作夥伴如何透過外部創新來建立其醫院產品組合。
  • 競爭與市場情報團隊
  • 按公司、適應症、目標、開發階段和技術追蹤合作趨勢,以了解不斷變化的策略重點。
  • 法律及交易團隊
  • 我們將仔細審查公開的合約和以往的合約結構,以幫助您準備和談判交易。
  • 我們將市場範圍內的醫院醫療保健資訊轉化為公司特定的見解。
  • 符合資格的客戶將收到 Current Partnering 的報告,以及為高階主管量身訂製的合作關係簡報。
  • 本簡報將運用有關醫院照護的交易情報,來分析您的具體資產、技術、適應症、目標或合作目標。
  • 如有需要,我們可以提供相關的類似交易、潛在的未來合作夥伴、競爭對手的活動、發展階段分析、交易結構、財務基準、忠誠度分析、合約見解以及其他專門為您情況選擇的資訊。
  • 請索取樣本或聯絡 Current Partnering 討論報告內容以及我們是否可以為貴公司提供客製化分析。

目錄

摘要整理

第1章:引言

第2章:醫院護理業交易趨勢

  • 醫院護理領域合作關係的長期趨勢
  • 按交易類型分類的醫院和醫療合作關係
  • 醫院護理領域的合作關係,按行業細分。
  • 按發展階段分類的醫院護理夥伴關係
  • 按技術類型分類的醫療領域合作夥伴關係
  • 基於治療指徵的醫院護理領域合作

第3章 醫院護理合作中的財務狀況

  • 醫院護理合作中揭露的財務條款
  • 醫院護理夥伴關係的主要交易價值
  • 醫院護理合約預付款
  • 醫院護理合約中的里程碑付款
  • 醫院護理忠誠度

第4章:大型醫院護理交易及交易商

  • 醫院護理合作領域最活躍的參與者
  • 醫院護理領域最活躍的交易商名單
  • 主要住院治療交易:按金額

第5章:醫院護理合約文件目錄

  • 可提供合約文件的醫院護理合作項目。

第6章:基於治療標靶的醫院護理交易

  • 醫院醫療保健交易:依治療標靶分類
  • 交易目錄
  • 交易目錄 - 醫院護理交易,依公司名稱排序(A-Z)
  • 交易目錄 - 按技術分類的醫院護理交易
  • 交易類型的定義
  • 關於生物製藥研究
  • Current Partnering
  • Current Agreements
  • 理想合作夥伴近期報告標題
簡介目錄
Product Code: CP2220

Understand the hospital care partnering landscape using intelligence from 842 real-world collaboration and licensing deals.

Hospital Care Collaboration and Licensing Deals 2016-2026 provides comprehensive intelligence on 842 partnering deals involving hospital care assets, technologies and development programs.

Hospital care partnering spans a broad range of acute, inpatient and hospital-delivered interventions, with transaction structures often shaped by clinical delivery requirements, specialist technologies, healthcare system integration and the operational demands of bringing products into hospital settings.

The report brings this activity together in one resource, enabling users to understand who is partnering, which hospital care opportunities are attracting interest, how transactions are structured, what financial terms have been disclosed and how dealmaking differs across therapeutic indications, technologies and stages of development.

Rather than simply providing a list of transactions, the report combines market-wide deal analysis with financial benchmarking, leading dealmaker intelligence, detailed transaction records and access to publicly available contract documents where available.

It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, corporate strategy, R&D strategy, competitive intelligence and legal teams involved in hospital care partnering.

Understand the hospital care partnering landscape

The report analyzes hospital care dealmaking from 2016 to 2026, including:

  • Trends in hospital care partnering by year
  • Deal activity by deal type
  • Industry sector
  • Stage of development at the time of partnering
  • Technology type
  • Therapeutic indication
  • Most active hospital care dealmakers
  • Leading deals by disclosed value
  • How hospital care partnering activity is evolving
  • This enables users to identify where activity is concentrated and understand which companies, technologies, development stages and therapeutic areas are attracting partnering interest.
  • Benchmark hospital care deal financials
  • Financial terms can vary considerably according to the asset, development stage, technology, rights granted and overall transaction structure.

The report provides dedicated analysis of disclosed financial terms, including:

  • Headline deal values
  • Upfront payments
  • Milestone payments
  • Royalty rates
  • Users can investigate the individual transactions behind these benchmarks to understand the wider context surrounding the disclosed economics.
  • This provides real-world reference points for internal benchmarking, opportunity assessment, deal preparation and negotiation.
  • Financial benchmarks are most useful when considered alongside the structure and circumstances of comparable transactions rather than as standalone averages, and the report provides the underlying deal intelligence needed to establish that context.
  • Identify leading hospital care dealmakers and prospective partners
  • The report identifies the most active companies in hospital care partnering and provides transaction histories that enable users to investigate their previous activity.

This can help users identify:

  • Companies actively seeking hospital care opportunities
  • Prospective licensing and collaboration partners
  • Organizations repeatedly partnering in relevant therapeutic areas
  • Companies active at relevant stages of development
  • Dealmakers demonstrating interest in specific technologies or delivery settings
  • Competitors pursuing related external innovation strategies
  • For companies seeking to partner a hospital care asset or technology, previous transaction activity can provide useful evidence of which organizations have demonstrated an appetite for comparable opportunities.
  • Compare partnering activity across hospital care indications and targets
  • Hospital care encompasses a diverse range of therapeutic needs and clinical settings, with different development, commercialization and implementation requirements.
  • The report analyzes partnering by therapeutic indication and therapeutic target, enabling users to move beyond broad market-level benchmarks and identify transactions most relevant to a particular program or strategic interest.
  • Combined with analysis by technology and development stage, this helps users identify more meaningful comparable transactions and prospective partners.
  • Understand how hospital care agreements are structured
  • The report includes collaboration, licensing, development, research and other partnering transactions.

Depending on the transaction and available disclosure, users can investigate areas including:

  • Rights granted and retained
  • Research and development responsibilities
  • Licensing rights
  • Exclusivity
  • Geographic rights
  • Intellectual property
  • Development and regulatory obligations
  • Manufacturing and supply responsibilities
  • Commercialization rights
  • Financial consideration
  • Milestones and royalties
  • Governance
  • Term and termination provisions
  • These real-world examples provide useful reference points when considering the appropriate structure for a hospital care partnership.
  • Learn from real-world contract documents
  • Where publicly available, the report provides access to underlying contract documents for selected hospital care transactions.

These agreements can provide substantially more detail than headline announcements alone, enabling users to examine how companies have documented areas such as:

  • Scope of rights
  • Development obligations
  • Intellectual property
  • Exclusivity
  • Financial terms
  • Milestone triggers
  • Royalty provisions
  • Commercialization rights
  • Termination and other negotiated provisions
  • For teams preparing or negotiating a hospital care collaboration or licensing agreement, access to real contract language provides valuable insight into how comparable deals have been structured in practice.
  • Comprehensive hospital care deal directory
  • The report includes a comprehensive directory of 842 hospital care collaboration and licensing deals, providing a detailed resource for identifying relevant precedent transactions.

Deals can be reviewed by:

  • Company
  • Technology type
  • Therapeutic indication or target
  • Contract availability
  • Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
  • Who should use this report?
  • Business Development and Licensing teams
  • Identify comparable hospital care transactions, prospective partners and relevant deal structures.
  • Search and Evaluation teams
  • Understand which companies are actively seeking hospital care opportunities across relevant indications, technologies and development stages.
  • Biotechnology Companies Seeking Partners
  • Identify organizations with demonstrated interest in comparable hospital care assets and technologies.
  • Corporate and R&D Strategy teams
  • Understand how competitors and prospective partners are building hospital-focused portfolios through external innovation.
  • Competitive and Market Intelligence teams
  • Track partnering activity by company, indication, target, development stage and technology to understand evolving strategic priorities.
  • Legal and Transaction teams
  • Review publicly available contracts and precedent agreement structures to support transaction preparation and negotiation.
  • Turn market-wide hospital care intelligence into company-specific insight
  • For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
  • The briefing applies the underlying hospital care deal intelligence to the customer's own asset, technology, indication, target or partnering objectives.
  • Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, development-stage analysis, deal structures, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
  • Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in hospital care dealmaking

  • 2.1. Introduction
  • 2.2. Hospital care partnering over the years
  • 2.3. Hospital care partnering by deal type
  • 2.4. Hospital care partnering by industry sector
  • 2.5. Hospital care partnering by stage of development
  • 2.6. Hospital care partnering by technology type
  • 2.7. Hospital care partnering by therapeutic indication

Chapter 3 - Financial deal terms for hospital care partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for hospital care partnering
  • 3.3. Hospital care partnering headline values
  • 3.4. Hospital care deal upfront payments
  • 3.5. Hospital care deal milestone payments
  • 3.6. Hospital care royalty rates

Chapter 4 - Leading hospital care deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in hospital care partnering
  • 4.3. List of most active dealmakers in hospital care
  • 4.4. Top hospital care deals by value

Chapter 5 - Hospital care contract document directory

  • 5.1. Introduction
  • 5.2. Hospital care partnering deals where contract document available

Chapter 6 - Hospital care dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by hospital care therapeutic target
  • Deal directory
  • Deal directory - Hospital care deals by company A-Z
  • Deal directory - Hospital care deals by technology type
  • Deal type definitions
  • About Biopharma Research Ltd
  • Current Partnering
  • Current Agreements
  • Recent report titles from Current Partnering

Table of figures

  • Figure 1: Hospital care partnering since 2016
  • Figure 2: Hospital care partnering by deal type since 2016
  • Figure 3: Hospital care partnering by industry sector since 2016
  • Figure 4: Hospital care partnering by stage of development since 2016
  • Figure 5: Hospital care partnering by technology type since 2016
  • Figure 6: Hospital care partnering by indication since 2016
  • Figure 7: Hospital care deals with a headline value
  • Figure 8: Hospital care deals with upfront payment values
  • Figure 9: Hospital care deals with milestone payment
  • Figure 10: Hospital care deals with royalty rates
  • Figure 11: Active hospital care dealmaking activity since 2016
  • Figure 12: Top hospital care deals by value since 2016